Innovation1 Biotech Inc.
IVBT · OTC
8/31/2023 | 8/31/2022 | 8/31/2021 | 8/31/2020 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | 160.8% | – |
| Cost of Goods Sold | $0 | $3 | $0 | $0 |
| Gross Profit | -$0 | -$3 | $0 | -$0 |
| % Margin | – | – | 53.9% | -151% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $1 | $2 | $0 | $0 |
| SG&A Expenses | $1 | $3 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$0 | $0 | $0 |
| Operating Expenses | $1 | $3 | $0 | $0 |
| Operating Income | -$1 | -$5 | -$0 | -$0 |
| % Margin | – | – | -8,390.9% | -18,374.3% |
| Other Income/Exp. Net | -$5 | -$36 | $1 | -$2 |
| Pre-Tax Income | -$6 | -$41 | $1 | -$3 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$6 | -$41 | $1 | -$3 |
| % Margin | – | – | 33,766.2% | -218,458.9% |
| EPS | -0.7 | -2.73 | 5.53 | -8.59 |
| % Growth | 74.4% | -149.4% | 164.4% | – |
| EPS Diluted | -0.7 | -2.73 | 5.53 | -8.59 |
| Weighted Avg Shares Out | 20 | 15 | 0 | 0 |
| Weighted Avg Shares Out Dil | 20 | 15 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $1 |
| Depreciation & Amortization | $0 | $3 | $0 | $0 |
| EBITDA | -$6 | -$38 | $1 | -$1 |
| % Margin | – | – | 40,941.6% | -108,382.7% |